Abner Herrman & Brock LLC Merck & Co., Inc. Transaction History

Abner Herrman & Brock LLC

  • $829 Million
  • Q3 2024

A detailed history of Abner Herrman & Brock LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Abner Herrman & Brock LLC holds 135,210 shares of MRK stock, worth $13.9 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
135,210
Previous 134,718 0.37%
Holding current value
$13.9 Million
Previous $16.7 Million 7.94%
% of portfolio
1.85%
Previous 2.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024
BUY
$111.15 - $128.97 $54,685 - $63,453
492 Added 0.37%
135,210 $15.4 Million
Q2 2024

Jul 18, 2024
SELL
$123.8 - $132.96 $474,277 - $509,369
-3,831 Reduced 2.77%
134,718 $16.7 Million
Q1 2024

Apr 09, 2024
SELL
$113.24 - $131.95 $338,361 - $394,266
-2,988 Reduced 2.11%
138,549 $18.3 Million
Q4 2023

Jan 09, 2024
SELL
$100.18 - $109.02 $252,553 - $274,839
-2,521 Reduced 1.75%
141,537 $15.4 Million
Q3 2023

Oct 10, 2023
SELL
$102.95 - $114.33 $5.47 Million - $6.07 Million
-53,107 Reduced 26.94%
144,058 $14.8 Million
Q2 2023

Jul 05, 2023
BUY
$108.61 - $118.38 $5,104 - $5,563
47 Added 0.02%
197,165 $22.8 Million
Q1 2023

Apr 13, 2023
SELL
$102.94 - $114.86 $8,441 - $9,418
-82 Reduced 0.04%
197,118 $21 Million
Q4 2022

Jan 04, 2023
SELL
$87.44 - $112.11 $77,559 - $99,441
-887 Reduced 0.45%
197,200 $21.9 Million
Q3 2022

Oct 06, 2022
BUY
$84.53 - $94.96 $544,795 - $612,017
6,445 Added 3.36%
198,087 $17.1 Million
Q2 2022

Jul 13, 2022
BUY
$83.49 - $94.64 $150,949 - $171,109
1,808 Added 0.95%
191,642 $17.5 Million
Q1 2022

Apr 07, 2022
BUY
$73.51 - $82.4 $14 Million - $15.6 Million
189,834 New
189,834 $15.6 Million
Q2 2021

Jul 09, 2021
SELL
$70.31 - $77.77 $13.5 Million - $14.9 Million
-192,054 Closed
0 $0
Q1 2021

Apr 09, 2021
SELL
$68.86 - $81.11 $1.77 Million - $2.08 Million
-25,655 Reduced 11.78%
192,054 $14.8 Million
Q4 2020

Jan 12, 2021
SELL
$71.77 - $79.65 $1.2 Million - $1.34 Million
-16,783 Reduced 7.16%
217,709 $17.8 Million
Q3 2020

Oct 08, 2020
SELL
$73.18 - $82.95 $630,152 - $714,282
-8,611 Reduced 3.54%
234,492 $19.5 Million
Q2 2020

Jul 10, 2020
SELL
$70.42 - $80.13 $1.14 Million - $1.3 Million
-16,167 Reduced 6.24%
243,103 $18.8 Million
Q1 2020

Apr 09, 2020
SELL
$63.36 - $87.82 $882,794 - $1.22 Million
-13,933 Reduced 5.1%
259,270 $19.9 Million
Q4 2019

Jan 10, 2020
SELL
$77.58 - $87.54 $1.85 Million - $2.08 Million
-23,800 Reduced 8.01%
273,203 $24.8 Million
Q3 2019

Oct 11, 2019
SELL
$76.08 - $82.93 $1.08 Million - $1.18 Million
-14,186 Reduced 4.56%
297,003 $25 Million
Q2 2019

Jul 19, 2019
SELL
$69.84 - $81.59 $231,100 - $269,981
-3,309 Reduced 1.05%
311,189 $26.1 Million
Q1 2019

Apr 08, 2019
SELL
$69.58 - $79.36 $21.7 Million - $24.7 Million
-311,385 Closed
0 $0
Q4 2018

Jan 11, 2019
BUY
$65.24 - $75.71 $2.81 Million - $3.26 Million
43,002 Added 16.02%
311,385 $23.8 Million
Q3 2018

Oct 19, 2018
BUY
$57.69 - $67.84 $821,909 - $966,516
14,247 Added 5.61%
268,383 $19 Million
Q2 2018

Jul 06, 2018
BUY
$50.83 - $59.72 $503,725 - $591,825
9,910 Added 4.06%
254,136 $15.4 Million
Q1 2018

Apr 06, 2018
BUY
$50.96 - $59.23 $661,817 - $769,220
12,987 Added 5.62%
244,226 $13.3 Million
Q4 2017

Jan 05, 2018
SELL
$51.62 - $61.64 $1.32 Million - $1.58 Million
-25,558 Reduced 9.95%
231,239 $13 Million
Q3 2017

Oct 06, 2017
BUY
$58.67 - $63.13 $15.1 Million - $16.2 Million
256,797
256,797 $16.4 Million

Others Institutions Holding MRK

# of Institutions
3,824
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Abner Herrman & Brock LLC Portfolio

Follow Abner Herrman & Brock LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email